July 17, 2024
Cell Therapy Manufacturing Market

Cell Therapy Manufacturing Is Driven By Rising Incidence Of Chronic Diseases

Cell therapy manufacturing involves developing cell culture media, reagents and consumables required to produce cell therapy products. Cell culture media provides optimum growth requirements for different cell types used in cell therapy such as stem cells, immune cells and different types of tissue specific cells. Reagents are used to support cell growth, selection, isolation and therapeutically modify cells. Consumables include plastic ware, accessories and other ancillary products required during cell therapy manufacturing process. Growing incidences of chronic diseases such as cancer, cardiovascular diseases and neurological disorders have triggered demand for new treatment options like cell therapy. Manufacturers are focusing on developing advanced cell culture media with well-defined compositions, optimized for large scale cell expansion able to support viable and functional cells.

The global Cell Therapy Manufacturing Market is estimated to be valued at US$ 12.99 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Advancements in 3D cell culture techniques are gaining traction in cell therapy manufacturing. 3D cell cultures mimic in vivo microenvironment better compared to conventional 2D models and support growth of cells in 3D structures. This enables simulation of tissue-tissue interactions and development of organoids. Many vendors offer 3D bioprinting solutions and spheroid formation plates to support 3D cell culturing in therapeutic development and manufacturing. Companies are also investing in continuous manufacturing technologies to achieve automated, closed and seamless manufacturing process of cell therapies aimed at improving production efficiency and yields. Developing centralized manufacturing facilities with standardized protocols and stringent quality controls can help lower production costs and ensure availability of cell therapies

Porter’s Analysis

Threat of new entrants: The cell therapy manufacturing market requires high investment for setting up production facilities making it difficult for new players to enter.
Bargaining power of buyers: The bargaining power of buyers is low as the market has few leading manufacturers who can offer cost-effective production services.
Bargaining power of suppliers: The suppliers have moderate bargaining power as they have capabilities to ramp up production as per demand.
Threat of new substitutes: There is no substitute available for cell therapies currently in the market.
Competitive rivalry: The competition in the market is high as leading players focus on expanding their product portfolio and manufacturing capabilities globally to gain market share.

Key Takeaways

The Global Cell Therapy Manufacturing Market Demand is expected to witness high growth over the forecast period of 2023 to 2030.

Regional analysis: North America accounts for the largest share in the cell therapy manufacturing market due to presence of advanced healthcare facilities and favorable government initiatives. Asia Pacific also offers lucrative opportunities and is expected to be the fastest growing region due to increasing patient pool and rising healthcare expenditure.

Key players operating in the cell therapy manufacturing market are SARAHEALTH SARE, MRK Healthcare Pvt. Ltd., Amkay Products Pvt. Ltd., JIT & JIT, Kanam Latex Industries Pvt. Ltd., RFB Latex Limited, Safeshield Gloves, Amigo Surgicare Pvt. Ltd., Asma Rubber Products Pvt. Ltd., Narang Medical Limited, Phoenix Medical Technologies & Imports, Manglam Medikits Private Limited, and VLHS. The major players are focusing on new product launches and collaborations with research institutes to strengthen their market position.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it